CD79A and COVID-19: Importantly, because of the comprehensive range of disease severity represented in our cohort, we were able to compare the opposite ends of the COVID-19 disease spectrum by focusing on individuals with mild disease as compared with patients with moderate/severe disease, who had the highest circulating IgG and IgA levels.